Tag: SHIELD trial

Last patient enrolled in SB-030 SHIELD trial for peripheral artery disease...

Symic Bio, has completed enrolment for the SHIELD clinical trial of SB-030 in peripheral artery disease. The trial will evaluate the safety and efficacy...